PharmTech News

Nov 14, 2018
Improving the manufacturing of gene therapy vectors will be crucial to making advanced treatments accessible to more patients who need them, agreed panelists at the 2018 Galien Forum.
Nov 14, 2018
By Pharmaceutical Technology Editors
The agency sent a warning letter to the company for marketing an unapproved stem cell product and CGMP violations.
Nov 12, 2018
By Pharmaceutical Technology Editors
GE Healthcare will collaborate with Wego Pharmaceutical in China for local production and supply of GE Healthcare’s Fortem single-use consumables.
Nov 12, 2018
By Pharmaceutical Technology Editors
The agency is developing a new way to assess, record, and report data from surveillance and preapproval inspections of sterile drugs.
Nov 09, 2018
More—and earlier—interaction between R&D and payers will be essential if innovative therapies are to become more accessible for patients, and more profitable for manufacturers, said panelists at the 2018 Galien Foundation Forum.
Nov 09, 2018
By Pharmaceutical Technology Editors
The new program will provide cell and gene therapy companies a more efficient way to ensure quality compliance across collection center networks and to minimize quality system audit burden on these centers.
Nov 09, 2018
By Pharmaceutical Technology Editors
Investigatory work arranged by Swissmedic has revealed that sartan-containing medicines on the Swiss market are safe in respect of NDMA.
Nov 08, 2018
By Pharmaceutical Technology Editors
AbbVie will grant Momenta license to launch a biosimilar to AbbVie’s Humira.
Nov 08, 2018
By Pharmaceutical Technology Editors
The expanded Frederick, MD, site will help meet global demand for diagnostic instruments and cell and gene therapies for clinical trials.
Nov 08, 2018
By Pharmaceutical Technology Editors
The decision follows an FDA request for additional information to complement the company’s submission for biosimilar rituximab.
native1_300x100
lorem ipsum